Age-related macular degeneration: experimental and emerging treatments

References

• RattnerANathansJMacular degeneration: recent advances and therapeutic opportunitiesNat Rev Neurosci20067118607217033682
   PubMed Web of Science ®Google Scholar
• FerraraNKerbelRSAngiogenesis as a therapeutic targetNature200543870709677416355214
   PubMed Web of Science ®Google Scholar
• VerheulHMPinedoHMPossible molecular mechanisms involved in the toxicity of angiogenesis inhibitionNat Rev Cancer2007764758517522716
   PubMed Web of Science ®Google Scholar
• FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol2002296 Suppl 1615812516034
   PubMed Web of Science ®Google Scholar
• NussenblattRBFerrisFAge-related macular degeneration and the immune response: implications for therapyAm J Ophthalmol200714446182617698021
   PubMed Web of Science ®Google Scholar
• ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature20014116836494811373684
   PubMed Web of Science ®Google Scholar
• FireAXuSMontgomeryMKKostasSADriverSEMelloCCPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature19983916669806119486653
   PubMed Web of Science ®Google Scholar
• WhelanJFirst clinical data on RNAiDrug Discov Today200510151014516055013
   PubMed Web of Science ®Google Scholar
• Hadj-SlimaneRLepelletierYLopezNGarbayCRaynaudFShort interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesisBiochimie2007891012344417707573
   PubMed Web of Science ®Google Scholar
• TolentinoMInterference RNA technology in the treatment of CNVOphthalmol Clin North Am2006193393916935214
   PubMedGoogle Scholar
• HannonGJRNA interferenceNature200241868942445112110901
   PubMed Web of Science ®Google Scholar
• KimDHRossiJJStrategies for silencing human disease using RNA interferenceNat Rev Genet2007831738417304245
   PubMed Web of Science ®Google Scholar
• ReichSJFosnotJKurokiASmall interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse modelMol Vis20039210612789138
   PubMed Web of Science ®Google Scholar
• TolentinoMJBruckerAJFosnotJYingGSWuIHMalikGWanSReichSJIntravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularizationRetina200424466015473063
   PubMed Web of Science ®Google Scholar
• SingermanLJBevasiranib for treatment of AMD and DMEOral presentation at The Retina SocietyBostonSept 28, 2007
   Google Scholar
• HolashJDavisSPapadopoulosNand al.VEGF-Trap: a VEGF blocker with potent antitumor effectsProc Natl Acad Sci U S A2002991711393812177445
   PubMed Web of Science ®Google Scholar
• SaishinYTakahashiKLimaERVEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrierJ Cell Physiol20031952241812652651
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSMHafizGCLEAR-AMD 1 Study GroupA phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degenerationOphthalmology200611391522.e11522.e1416876249
   PubMed Web of Science ®Google Scholar
• CampochiaroPAPotential applications for RNAi to probe pathogenesis and develop new treatments for ocular disordersGene Ther20061365596216195702
   PubMed Web of Science ®Google Scholar
• WhelanJFirst clinical data on RNAiDrug Discov Today200510151014516055013
   PubMed Web of Science ®Google Scholar
• ShenJSamulRSilvaRLSuppression of ocular neovascularization with siRNA targeting VEGF receptor 1Gene Ther20061332253416195704
   PubMed Web of Science ®Google Scholar
• AkiyamaHMohamedaliKAE SilvaRLVascular targeting of ocular neovascularization with a vascular endothelial growth factor121. gelonin chimeric proteinMol Pharmacol200568615435016150930
   PubMed Web of Science ®Google Scholar
• SaishinYSilvaRLSaishinYPeriocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine modelInvest Ophthalmol Vis Sci2003441149899314578426
   PubMed Web of Science ®Google Scholar
• TakedaAHataYShioseSSuppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitorGraefes Arch Clin Exp Ophthalmol200324197657212937991
   PubMed Web of Science ®Google Scholar
• WangFEShiGNiesmanMRRewolinskiDAMillerSSReceptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eyeExp Eye Res20078459223317399700
   PubMed Web of Science ®Google Scholar
• KinoseFRoscilliGLamartinaSInhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitorMol Vis2005113667315951738
   PubMed Web of Science ®Google Scholar
• TakahashiHObataRTamakiYA novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivoJ Ocul Pharmacol Ther2006224213816910860
   PubMed Web of Science ®Google Scholar
• RegilloCDD’AmicoDJMielerWFSchneebaumCBeasleyCHSullinsGTClinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degenerationSurv Ophthalmol200752Suppl 1S70817240259
   PubMed Web of Science ®Google Scholar
• RussellSRHudsonHLJerdanJAAnecortave Acetate Clinical Study GroupAnecortave acetate for the treatment of exudative age-related macular degeneration – a review of clinical outcomesSurv Ophthalmol200752Suppl 1S799017240260
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUMichelsSMichelsRAueAAnecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degenerationEur J Ophthalmol2005154482516001382
   PubMed Web of Science ®Google Scholar
• D’AmicoDJGoldbergMFHudsonHAnecortave Acetate Clinical Study GroupAnecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomesOphthalmology200311012237283discussion 2384–514644721
   PubMed Web of Science ®Google Scholar
• SlakterJSComplement C3 inhibitor POT-4: Pre-clinical safety of intra-vitreal and systemic administrationOral presentation, The Retina SocietyBostonSeptember 2007
   Google Scholar
• EichlerWYafaiYWiedemannPFenglerDAntineovascular agents in the treatment of eye diseasesCurr Pharm Des2006122126456016842164
   PubMed Web of Science ®Google Scholar
• SaishinYSilvaRLSaishinYPeriocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eyeHum Gene Ther2005164473815871678
   PubMed Web of Science ®Google Scholar
• TongJPYaoYFContribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressionsClin Biochem20063932677616409998
   PubMed Web of Science ®Google Scholar
• DuhEJYangHSSuzumaIPigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growthInvest Ophthalmol Vis Sci2002433821911867604
   PubMed Web of Science ®Google Scholar
• MoriKGehlbachPAndoAMcVeyDWeiLCampochiaroPARegression of ocular neovascularization in response to increased expression of pigment epithelium-derived factorInvest Ophthalmol Vis Sci200243724283412091447
   PubMed Web of Science ®Google Scholar
• CashmanSMBowmanLChristoffersonJKumar-SinghRInhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMDInvest Ophthalmol Vis Sci2006478349650416877421
   PubMed Web of Science ®Google Scholar
• SheuSJChouLCBeeYSSuppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatinExp Eye Res2005128166739Epub 2005 Jun 20.15967435
   PubMed Web of Science ®Google Scholar
• HigginsRDYanYGengYZasloffMWilliamsJIRegression of retinopathy by squalamine in a mouse modelPediatr Res2004561144915128931
   PubMed Web of Science ®Google Scholar
• HigginsRDSandersRJYanYZasloffMWilliamsJISqualamine improves retinal neovascularizationInvest Ophthalmol Vis Sci200041615071210798670
   PubMed Web of Science ®Google Scholar
• NambuHNambuRMeliaMCampochiaroPACombretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularizationInvest Ophthalmol Vis Sci20034483650512882819
   PubMed Web of Science ®Google Scholar
• EmersonMVLauerAKEmerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edemaBioDrugs20072142455717628122
   PubMed Web of Science ®Google Scholar
• SenguptaNCaballeroSMamesRNButlerJMScottEWGrantMBThe role of adult bone marrow-derived stem cells in choroidal neovascularizationInvest Ophthalmol Vis Sci2003441149081314578416
   PubMed Web of Science ®Google Scholar
• Espinosa-HeidmannDGSunerIJHernandezEPMonroyDCsakyKGCousinsSWMacrophage depletion diminishes lesion size and severity in experimental choroidal neovascularizationInvest Ophthalmol Vis Sci200344835869212882811
   PubMed Web of Science ®Google Scholar
• NoelAJostMLambertVLecomteJRakicJMAnti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging conceptsTrends Mol Med20071383455217644433
   PubMed Web of Science ®Google Scholar
• PetrukhinKNew therapeutic targets in atrophic age-related macular degenerationExpert Opin Ther Targets20071156253917465722
   PubMed Web of Science ®Google Scholar
• LandaGImmune-based systemic therapy with copaxone for dry AMDThe Retina society, Boston, 9292007
   Google Scholar
• HudsonHLLaneSSHeierJSIMT-002 Study GroupImplantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year resultsOphthalmology2006113111987200116989902
   PubMed Web of Science ®Google Scholar
• LaneSSKuppermannBDThe Implantable Miniature Telescope for macular degenerationCurr Opin Ophthalmol200617194816436930
   PubMed Web of Science ®Google Scholar
• HeeMRBaumalCRPuliafitoCAOptical coherence tomography of age-related macular degeneration and choroidal neovascularizationOphthalmology19961031260708764797
   PubMed Web of Science ®Google Scholar
• RogersAHMartidisAGreenbergPBOptical coherence tomography findings following photodynamic therapy of choroidal neovascularizationAm J Ophthalmol20021345667612383814
   PubMed Web of Science ®Google Scholar
• RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascularOphthalmic Surg Lasers Imaging2005364331516156152
   PubMed Web of Science ®Google Scholar
• SandhuSSTalksSJCorrelation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranesBr J Ophthalmol2005899677016024845
   PubMed Web of Science ®Google Scholar
• Salinas-AlamanAGarcia-LayanaAMaldonadoMJUsing optical coherence tomography to monitor photodynamic therapy in age related macular degenerationAm J Ophthalmol200514023815922284
   PubMed Web of Science ®Google Scholar
• DoreyCKWuGEbensteinDCell loss in the aging retina. Relationship to lipofuscin accumulation and macular degenerationInvest Ophthalmol Vis Sci198930169192759786
   PubMed Web of Science ®Google Scholar
• SpaideRFFundus autofluorescence and age-related macular degenerationOphthalmology2003110392912578786
   PubMed Web of Science ®Google Scholar
• HolzFGBellmannCMargaritidisMPatterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degenerationGraefes Arch Clin Exp Ophthalmol1999237145529987631
   PubMed Web of Science ®Google Scholar
• EinbockWMoessnerASchnurrbuschUEFAM Study GroupChanges in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective studyGraefes Arch Clin Exp Ophthalmol2005243300515864618
   PubMed Web of Science ®Google Scholar
• KirkpatrickJNManivannanAGuptaAKFundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscopeBr J Ophthalmol19957989297488576
   PubMed Web of Science ®Google Scholar
• SeddonJMCoteJPageWFThe US twin study of age-related macular degeneration: relative roles of genetic and environmental influencesArch Ophthalmol2005123321715767473
   PubMed Web of Science ®Google Scholar
• DesprietDDKlaverCCWittemanJCComplement factor H polymorphism, complement activators, and risk of age-related macular degenerationJAMA2006296301916849663
   PubMed Web of Science ®Google Scholar
• JakobsdottirJConleyYPWeeksDEMahTSFerrellREGorinMBSusceptibility genes for age-related maculopathy on chromosome 10q26Am J Hum Genet200577338940716080115
   PubMed Web of Science ®Google Scholar
• AllikmetsRWassermanWWHutchinsonAOrganization of the ABCR gene: analysis of promoter and splice junction sequencesGene19982151111229666097
   PubMed Web of Science ®Google Scholar
• AllikmetsRShroyerNFSinghNMutation of the Stargardt disease gene (ABCR) in age-related macular degenerationScience19972775333180579295268
   PubMed Web of Science ®Google Scholar
• TuoJSmithBCBojanowskiCMThe involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degenerationFASEB J200418111297915208270
   PubMed Web of Science ®Google Scholar
• StoneEMBraunTARussellSRMissense variations in the fibulin 5 gene and age-related macular degenerationN Engl J Med200422;35143465315269314
   PubMed Web of Science ®Google Scholar